ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Nurse Practitioner, Family

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,244Medicare Part D Prescriptions Filled, Including Refills

Rank: 4 out of 251

$566K Total Retail Price of All Prescriptions

Rank: 10 out of 251

480 Patients Receiving at Least One Drug in Part D
64%Patients 65 Years and Older
65% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in South Carolina
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

24% of this provider’s 480 patients filled at least one prescription for a schedule three drug, compared to an average of 13%.

Risky Drugs to Seniors

3% of this provider’s 6,203 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $65 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 12.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in South Carolina
HYDROCODONE-ACETAMINOPHEN 693 367 S3 1 2
SIMVASTATIN 362 263 2 6
LISINOPRIL 346 194 3 3
OMEPRAZOLE 313 177 4 5
PRAVASTATIN SODIUM 291 211 5 7
METFORMIN HCL 284 177 6 8
HYDROCHLOROTHIAZIDE 268 201 7 10
ZOLPIDEM TARTRATE 248 115 8 19
TRAMADOL HCL 238 114 9 16
AMLODIPINE BESYLATE 209 136 10 1
LEVOTHYROXINE SODIUM 196 165 11 4
LOSARTAN-HYDROCHLOROTHIAZIDE 167 126 12 41
CRESTOR 159 81 13 20
ATORVASTATIN CALCIUM 153 68 14 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 138 106 15 14
METOPROLOL SUCCINATE 132 99 16 22
LOSARTAN POTASSIUM 128 118 17 29
FUROSEMIDE 126 102 18 9
NEXIUM 115 48 19 18
POTASSIUM CHLORIDE 112 75 20 17
CITALOPRAM HBR 102 40 21 32
RANITIDINE HCL 101 56 22 15
METOPROLOL TARTRATE 100 70 23 11
CYCLOBENZAPRINE HCL 95 18 R 24 45
ATENOLOL 93 70 25 28
NAPROXEN 92 30 26 96
GABAPENTIN 87 28 27 13
CARVEDILOL 86 51 28 21
WARFARIN SODIUM 83 69 29 38
MELOXICAM 82 55 30 27
CLOPIDOGREL 81 65 31 35
FAMOTIDINE 80 56 32 51
CELEBREX 73 50 33 88
VENTOLIN HFA 70 28 34 70
ACTOS 70 54 34 94
SPIRONOLACTONE 68 51 36 74
GLYBURIDE-METFORMIN HCL 67 60 R 37 95
PREDNISONE 66 46 38 23
PROAIR HFA 63 0 39 42
SERTRALINE HCL 61 28 40 25
LOVASTATIN 60 60 41 52
PLAVIX 60 38 41 50
COMBIVENT 59 33 43 92
AMITRIPTYLINE HCL 56 19 R 44 47
LYRICA 56 0 44 59
CYMBALTA 55 0 46 37
AMLODIPINE BESYLATE-BENAZEPRIL 54 50 47 36
VENLAFAXINE HCL ER 53 0 48 87
VERAPAMIL ER 53 50 48 169
DONEPEZIL HCL 53 42 48 56
TIZANIDINE HCL 51 0 51 58
FENOFIBRATE 50 30 52 61
PROMETHAZINE HCL 50 12 R 52 101
LAMOTRIGINE 50 0 52 101
FLUTICASONE PROPIONATE 50 35 52 33
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Oct. 29, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.